Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics Revenue

Nurix Therapeutics had revenue of $6.25M in the quarter ending February 28, 2026, a decrease of -66.12%. This brings the company's revenue in the last twelve months to $71.78M, up 27.23% year-over-year. In the fiscal year ending November 30, 2025, Nurix Therapeutics had annual revenue of $83.98M with 53.95% growth.

• Revenue (ttm): $71.78M
• Revenue Growth: +27.23%
• P/S Ratio: 34.53
• Revenue / Employee: $226,432
• Employees: 317
• Market Cap: 2.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Nov 30, 2025	83.98M	29.43M	53.95%
Nov 30, 2024	54.55M	-22.44M	-29.15%
Nov 30, 2023	76.99M	38.36M	99.31%
Nov 30, 2022	38.63M	8.88M	29.84%
Nov 30, 2021	29.75M	11.93M	66.95%
Nov 30, 2020	17.82M	-13.30M	-42.73%
Nov 30, 2019	31.12M	-6.33M	-16.91%
Nov 30, 2018	37.45M	-	-

Data Source: Fiscal.ai Last updated: Apr 8, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error